NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Knopp Biosciences

Knopp Biosciences

Private
Pittsburgh, PennsylvaniaHealthcare & Life Scienceshttps://knoppbio.com/

Last Round

Series C

Nov 11, 2020

Total Funding Raised

$124.66M

Company Overview

Knopp Biosciences is a biopharmaceutical company that manages a portfolio of equity securities and future product royalties following the divestiture of its drug development programs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Data as a Service

AI Layer

Non-AI

Keywords

biotechnologydrug discoverysmall-molecule therapeuticsclinical-stage biotechdexpramipexoleeosinophilic asthmahypereosinophilic syndromespharmaceutical licensingclinical trialsbiotech licensingdrug developmentbiopharmaKv7 ion-channelpharma spin-offtherapeutic development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Knopp Biosciences Comparables

Compare Knopp Biosciences with similar companies based on industry and business-model similarity.

Knopp Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Areteia Therapeutics
91%
Kinaset Therapeutics
77%
Sitryx
76%

Knopp Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CNov 11, 2020
GrantSep 26, 2019
VC RoundJul 9, 2019
GrantSep 5, 2018
GrantOct 23, 2017
VC Round
Sep 30, 2015

Knopp Biosciences Investors

Notable investors and investment history

Knopp Biosciences investors
InvestorRounds
NIH RADxGrant
Innovation WorksSeries A
Kramer Capital PartnersSeries C, Series B, Series A
LaunchCyte LLCSeries B, Series A
National Institutes of Health (NIH)Grant
Saturn PartnersSeries C, Series B, Series A
Chuangxin Innovation WorksSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2020

    $14M round led by Solas BioVentures

  • Sep 26, 2019

    $8M grant received from the National Institutes of Health.

Knopp Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Knopp Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Knopp Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania
Employee Range8
Year Founded2004
Last FundingNov 11, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.